Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Bioregenx (BRGX) Shares Outstanding (2021 - 2025)

Bioregenx has reported Shares Outstanding over the past 5 years, most recently at $969.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 1.26% year-over-year to $969.0 million; the TTM value through Dec 2025 reached $969.0 million, up 1.26%, while the annual FY2025 figure was $969.0 million, 1.26% up from the prior year.
  • Shares Outstanding for Q3 2025 was $962.0 million at Bioregenx, up from $3800.0 in the prior quarter.
  • Over five years, Shares Outstanding peaked at $962.0 million in Q3 2025 and troughed at $3800.0 in Q4 2022.
  • A 5-year average of $418.4 million and a median of $269.7 million in 2022 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: surged 25183955.26% in 2024 and later plummeted 100.0% in 2025.
  • Year by year, Shares Outstanding stood at $269.7 million in 2021, then surged by 181.64% to $759.7 million in 2022, then plummeted by 100.0% to $3800.0 in 2023, then surged by 25183955.26% to $957.0 million in 2024, then grew by 1.26% to $969.0 million in 2025.
  • Business Quant data shows Shares Outstanding for BRGX at $969.0 million in Q4 2025, $962.0 million in Q3 2025, and $961.2 million in Q2 2025.